In vivo self-assembled nano-PROTAC for the dual degradation of AR and HSP90 to overcome castration-resistant prostate cancer resistance. - Yang FY; Zhang NY; Yang Y; Chen D; Wu LY; Wang WK; Wang HX; Wen Z; Cai MZ; Li HZ; Huang H; An HW; et al. (Signal transduction and targeted therapy, 2025)